PARPi related toxicities: do we need more appropriate instruments to evaluate it?

被引:3
作者
Lorusso, D. [1 ]
Pignata, S. [2 ]
机构
[1] Fdn IRCCS Ist Nazl Tumori, Gynecol Oncol Unit, Milan, Italy
[2] Ist Nazl Tumori Napoli IRCCS Fdn G Pascale, Dept Urol & Gynecol, Naples, Italy
关键词
PATIENT-REPORTED OUTCOMES; QUALITY-OF-LIFE; COMMON TERMINOLOGY CRITERIA; RELAPSED OVARIAN-CANCER; MAINTENANCE THERAPY; BRCA1/2; MUTATION; ADVERSE EVENTS; CHEMOTHERAPY; SYMPTOMS;
D O I
10.1093/annonc/mdy189
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1613 / 1616
页数:5
相关论文
共 21 条
[1]   Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study [J].
Basch, Ethan ;
Iasonos, Alexia ;
McDonough, Tiffani ;
Barz, Allison ;
Culkin, Ann ;
Kris, Mark G. ;
Scher, Howard I. ;
Schrag, Deborah .
LANCET ONCOLOGY, 2006, 7 (11) :903-909
[2]   Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial [J].
Basch, Ethan ;
Pugh, Stephanie L. ;
Dueck, Amylou C. ;
Mitchell, Sandra A. ;
Berk, Lawrence ;
Fogh, Shannon ;
Rogak, Lauren J. ;
Gatewood, Marcha ;
Reeve, Bryce B. ;
Mendoza, Tito R. ;
O'Mara, Ann M. ;
Denicoff, Andrea M. ;
Minasian, Lori M. ;
Bennett, Antonia V. ;
Setser, Ann ;
Schrag, Deborah ;
Roof, Kevin ;
Moore, Joan K. ;
Gergel, Thomas ;
Stephans, Kevin ;
Rimner, Andreas ;
DeNittis, Albert ;
Bruner, Deborah Watkins .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (02) :409-418
[3]   Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) [J].
Basch, Ethan ;
Reeve, Bryce B. ;
Mitchell, Sandra A. ;
Clauser, Steven B. ;
Minasian, Lori M. ;
Dueck, Amylou C. ;
Mendoza, Tito R. ;
Hay, Jennifer ;
Atkinson, Thomas M. ;
Abernethy, Amy P. ;
Bruner, Deborah W. ;
Cleeland, Charles S. ;
Sloan, Jeff A. ;
Chilukuri, Ram ;
Baumgartner, Paul ;
Denicoff, Andrea ;
St Germain, Diane ;
O'Mara, Ann M. ;
Chen, Alice ;
Kelaghan, Joseph ;
Bennett, Antonia V. ;
Sit, Laura ;
Rogak, Lauren ;
Barz, Allison ;
Paul, Diane B. ;
Schrag, Deborah .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (09)
[4]   The Missing Voice of Patients in Drug-Safety Reporting [J].
Basch, Ethan .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (10) :865-869
[5]   Effect of chemotherapy for advanced non-small cell lung cancer on patients' quality of life - A randomized controlled trial [J].
Belani, Chandra P. ;
Pereira, Jose R. ;
von Pawel, Joachim ;
Pluzanska, Anna ;
Gorbounova, Vera ;
Kaukel, Eckhard ;
Mattson, Karin V. ;
Ramlau, Rodryg ;
Szczesna, Aleksandra ;
Fidias, Panos ;
Millward, Michael ;
Fossella, Frank .
LUNG CANCER, 2006, 53 (02) :231-239
[6]   Safety and dose modification for patients receiving niraparib [J].
Berek, J. S. ;
Matulonis, U. A. ;
Peen, U. ;
Ghatage, P. ;
Mahner, S. ;
Redondo, A. ;
Lesoin, A. ;
Colombo, N. ;
Vergote, I. ;
Rosengarten, O. ;
Ledermann, J. ;
Pineda, M. ;
Ellard, S. ;
Sehouli, J. ;
Gonzalez-Martin, A. ;
Berton-Rigaud, D. ;
Madry, R. ;
Reinthaller, A. ;
Hazard, S. ;
Guo, W. ;
Mirza, M. R. .
ANNALS OF ONCOLOGY, 2018, 29 (08) :1784-1792
[7]  
Bhattacharya Debi, 2012, J Oncol Pharm Pract, V18, P333, DOI 10.1177/1078155211436022
[8]   PARP inhibitors: Clinical utility and possibilities of overcoming resistance [J].
Bitler, Benjamin G. ;
Watson, Zachary L. ;
Wheeler, Lindsay J. ;
Behbakht, Kian .
GYNECOLOGIC ONCOLOGY, 2017, 147 (03) :695-704
[9]   Quality of Life Measurements: Any Value for Clinical Practice? [J].
Buettner, Matthias ;
Zebralla, Veit ;
Dietz, Andreas ;
Singer, Susanne .
CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2017, 18 (05)
[10]   Patient-reported outcomes in the evaluation of toxicity of anticancer treatments [J].
Di Maio, Massimo ;
Basch, Ethan ;
Bryce, Jane ;
Perrone, Francesco .
NATURE REVIEWS CLINICAL ONCOLOGY, 2016, 13 (05) :319-325